Pediatrix Medical MD 深 滬
等待開盤 11-05 09:30:00 美东时间
33.005
+2.405
+7.86%
華盛通- 最 高33.20
- 今 開31.27
- 成交量 43.36万股
- 最 低 31.01
- 昨 收 30.60
- 總市值 25.79亿
- 52周最高 33.20
- 市盈率 靜 17.02
- 換手率 0.55%
- 52周最低 17.23
- 委 比 98.92%
- 總股本 7812.47万
- 歷史最高 112.89
- 量 比 0.67
- 振 幅 7.16%
- 歷史最低 6.62
- 每 手 1
- 風險率 2.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅332.55%！Viking Therapeutics获上调目标价至118美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至118美元；Canaccord Genuity：维持Aclaris Therapeutics"买入"评级，目标价从10美元升至13美元
11-02 18:53
电话会总结 ｜ Pediatrix(MD)2026财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 财务业绩： - **净营收（Net Revenue）**：本季度净营收为5.014亿美元，同比增长1.7%，增长主要由收购活动驱动，同时同店营收（same-unit revenue）增长0.6%。 - **调整后EBITDA（Adjusted EBITDA）**：本季度为8550万美元，低于去年同期的8730万美元。 - **调整后每股收益（Adjusted EPS）**：为0.72美元，较2025年第三季度的0.67美元有所增长。 - **薪资与福利支出（Salaries and Benefits）**：本季度为3.415亿美元，临床薪资增长保持在
10-30 13:01
佩蒂特里克斯医疗集团 (MD) 2026年第三季度业绩电话会议：EBITDA展望收窄
Pediatrix Medical Group 2026 财年第三季度业绩电话会议涵盖了 8500 万美元的调整后 EBITDA、0.6% 的同单位增长以及 2.9 亿至 3 亿美元的业绩展望。
10-29 21:54
Pediatrix Medical Group shares are trading higher after the company reported better-than-expected Q3 financial results.
Pediatrix Medical Group shares are trading higher after the company reported better-than-expected Q3 financial results.
10-29 21:06
Pediatrix Medical Group Q3 Adj. EPS $0.72 Beats $0.65 Estimate, Sales $501.374M Beat $498.144M Estimate
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.65 by 10.77 percent. This is a 7.46 percent increase over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $501.374 mill...
10-29 18:13
Pediatrix Q3 2026 Earnings: Revenue Rises but Expense Pressure Weighs on EBITDA
Pediatrix Medical Group’s Q3 2026 revenue increased 1.7% to $501.4 million, but adjusted EBITDA slipped to $85.5 million as salaries and G&A grew faster than revenue. GAAP EPS fell to $0.59 from $0.84, partly because Q3 2025 included a $20.9 million investment gain, while adjusted EPS rose to $0.72 as the share count declined. Cash from continuing operations was $117.7 million, same-unit revenue grew 0.6%, and full-year adjusted EBITDA guidance w
10-29 10:14
Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST),Westwood Salient Enhanced Energy Income ETF (WEEI) and Westwood Enhanced Income Opportunity (YLDW)
Westwood Holdings Group announced monthly income distributions for three ETFs: MDST, WEEI, and YLDW. MDST and WEEI both distribute $0.225 per share with annualized rates of 9.8% and 11.2%, respectively, while YLDW distributes $0.180 per share at an 8.7% annualized rate. These funds combine dividend yields and options premiums to provide monthly income, targeting energy sector investments. MDST focuses on midstream energy companies, WEEI on broad ...
10-12 12:00
美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Morgan Stanley analyst Gary Yu downgraded Baidu Inc (NASDAQ:BIDU) from Equal-Weight to Underweigh...
08-19 20:52
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
08-19 20:36
